MedPath

Sugar Sweetened Beverage Labeling Support

Not Applicable
Completed
Conditions
Consumer Behavior
Registration Number
NCT02947802
Lead Sponsor
Harvard University
Brief Summary

This is an online survey assessing consumer support for different labeling policies related to sugar sweetened beverages. The investigators will present consumers with three labels that are being considered for sugar sweetened beverages: a calorie label, a text warning label that says "Warning drinking beverages with added sugar(s) can lead to health problems like obesity, diabetes and tooth decay" and a graphic warning label that includes graphic images to correspond with each of the health problems listed with the text warning. The investigators will ask participants their support for each label. The investigators will also see if support for the labels change after learning of the effectiveness of these labels. The investigators will share the results of a recent field study that suggested calorie and textual warning labels had no influence on the purchasing of sugar sweetened beverages while the graphic label decreased purchasing by 11 percent.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
400
Inclusion Criteria
  • The investigators will recruit a nationally representative sample using ClearVoice, a company that recruits online survey takers.
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Rate Support of a Label on a 1 (not at all) to 7 (a great deal) Scale.Immediately following the presentation of the labels.

Participants will rate their support of the label on a 1 (not at all) to 7 (a great deal)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Harvard University

🇺🇸

Cambridge, Massachusetts, United States

Harvard University
🇺🇸Cambridge, Massachusetts, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.